Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-04

Clinical Trial Update: A Study to Evaluate the Safety and Clinical Efficacy of STR-P004 [EARLY_Phase 1]

View source ↗

Summary

A clinical trial update shows STR-P004 for Non-Hodgkin lymphoma is in early Phase 1 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • STR-P004

Snippet

Sponsor: Starna Therapeutics | Conditions: Non Hodgkin Lymphoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING